The Female Health Company (NASDAQ: FHCO) manufactures and markets the FC2 Female Condom^® (FC2). The company owns certain worldwide rights to the FC2 Female Condom^®, including patents that have been issued in a number of countries around the world. The patents cover key aspects of FC2, including overall design and manufacturing process. The FC2 Female Condom^® is the only currently available female-controlled product approved by FDA that offers dual protection against sexually transmitted infections, including HIV/AIDS, and unintended pregnancy. For more information, visit the company’s website at www.femalehealth.com